Skip to main content
. 2013 Nov 12;8(11):e79634. doi: 10.1371/journal.pone.0079634

Table 2. Cox proportional hazards analysis of overall survival in stage I-II.

HS3ST2 hypermethylation HRa 95% CIa P-value
(A) Node-positive cases No 1.00
(N=55) Yes 0.84 0.34–3.82 0.69
(B) Node-negative cases No 1.00
(N=193) Yes 2.12 1.25–3.58 0.005

Adjusted for age, sex, tumor size, adjuvant therapy, recurrence, and differentiation

a

HR, hazard ratio; CI, confidence interval

NSCLCs (N = 248).